DE69418865D1 - Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten - Google Patents

Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten

Info

Publication number
DE69418865D1
DE69418865D1 DE69418865T DE69418865T DE69418865D1 DE 69418865 D1 DE69418865 D1 DE 69418865D1 DE 69418865 T DE69418865 T DE 69418865T DE 69418865 T DE69418865 T DE 69418865T DE 69418865 D1 DE69418865 D1 DE 69418865D1
Authority
DE
Germany
Prior art keywords
vitamin
east
compositions containing
containing pdgf
growth compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69418865T
Other languages
English (en)
Other versions
DE69418865T2 (de
Inventor
Emma Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DE69418865D1 publication Critical patent/DE69418865D1/de
Publication of DE69418865T2 publication Critical patent/DE69418865T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69418865T 1993-03-29 1994-03-29 Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten Expired - Lifetime DE69418865T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3832593A 1993-03-29 1993-03-29
PCT/US1994/003331 WO1994022463A1 (en) 1993-03-29 1994-03-29 Oesteoblast growth stimulating compostion containing pdgf and vitamin d

Publications (2)

Publication Number Publication Date
DE69418865D1 true DE69418865D1 (de) 1999-07-08
DE69418865T2 DE69418865T2 (de) 2000-02-17

Family

ID=21899306

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418865T Expired - Lifetime DE69418865T2 (de) 1993-03-29 1994-03-29 Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten

Country Status (14)

Country Link
US (1) US5533836A (de)
EP (1) EP0691849B1 (de)
JP (1) JP3699111B2 (de)
KR (1) KR960701648A (de)
CN (1) CN1104257C (de)
AT (1) ATE180674T1 (de)
AU (1) AU681879B2 (de)
CA (1) CA2159449C (de)
DE (1) DE69418865T2 (de)
DK (1) DK0691849T3 (de)
ES (1) ES2132399T3 (de)
GR (1) GR3030402T3 (de)
RU (1) RU2140282C1 (de)
WO (1) WO1994022463A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700289A (en) * 1995-10-20 1997-12-23 North Shore University Hospital Research Corporation Tissue-engineered bone repair using cultured periosteal cells
KR20000022040A (ko) 1996-06-20 2000-04-25 보오드 오브 리젠츠, 더 유니버시티 오브 텍사스 시스템 약학적 활성 제제를 제공하기 위한 화합물, 방법 및 그의 용도
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6042855A (en) * 1997-06-27 2000-03-28 United States Of America (Usda) Use of vitamin D, its metabolites and analogs to improve tenderness of meat and meat products
JP2001527030A (ja) * 1997-12-31 2001-12-25 デピュイ・オーソピーディックス・インコーポレイテッド 骨修復効果を向上するためのオステオポンチンを基剤とする組成物
US6551355B1 (en) 1998-08-14 2003-04-22 Cambridge Scientific, Inc. Tissue transplant coated with biocompatible biodegradable polymer
US6663870B2 (en) * 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
WO2001032197A2 (en) * 1999-11-02 2001-05-10 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8114841B2 (en) * 2004-10-14 2012-02-14 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
CA2641860C (en) 2006-02-09 2015-07-14 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
ES2664229T3 (es) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP3181157B1 (de) 2006-11-03 2019-08-14 BioMimetic Therapeutics, LLC Zusammensetzungen und verfahren für behandlungen von arthrodese
CN105854074B (zh) * 2008-02-07 2019-10-15 生物模拟治疗有限责任公司 用于牵引成骨术的组合物和方法
BE1018748A3 (fr) 2008-05-07 2011-08-02 Bone Therapeutics Sa Nouvelles cellules souches mesenchymateuses et cellules osteogeniques .
JPWO2010021162A1 (ja) * 2008-08-19 2012-01-26 国立大学法人大阪大学 骨組織再生用の細胞製剤
AU2009291828C1 (en) 2008-09-09 2016-03-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
US8492335B2 (en) 2010-02-22 2013-07-23 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
SG10201605895QA (en) * 2012-02-01 2016-09-29 Organ Technologies Inc Dental implant and method for producing same
EP3206670A4 (de) 2014-10-14 2018-06-20 Samuel Lynch Zusammensetzung zur behandlung von wunden

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
CA1322714C (en) * 1986-11-14 1993-10-05 Harry N. Antoniades Wound healing and bone regeneration
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
WO1992021365A1 (en) * 1991-06-05 1992-12-10 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US5129691A (en) * 1991-08-20 1992-07-14 Mcfarlen Jonn Gate latch control device

Also Published As

Publication number Publication date
CA2159449C (en) 1999-09-14
US5533836A (en) 1996-07-09
KR960701648A (ko) 1996-03-28
WO1994022463A1 (en) 1994-10-13
CN1121693A (zh) 1996-05-01
AU681879B2 (en) 1997-09-11
JPH08508499A (ja) 1996-09-10
EP0691849B1 (de) 1999-06-02
ATE180674T1 (de) 1999-06-15
RU2140282C1 (ru) 1999-10-27
AU6417194A (en) 1994-10-24
EP0691849A1 (de) 1996-01-17
CN1104257C (zh) 2003-04-02
DE69418865T2 (de) 2000-02-17
ES2132399T3 (es) 1999-08-16
DK0691849T3 (da) 1999-12-13
JP3699111B2 (ja) 2005-09-28
CA2159449A1 (en) 1994-10-13
GR3030402T3 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
DE69418865D1 (de) Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten
ATE142693T1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
EP0339607A3 (en) Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant
DE69429450D1 (de) Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ATE210992T1 (de) Injizierbare zusammensetzungen zur vergrösserung von weichgewebe
DE69025922D1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
NO921875D0 (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
ATE186840T1 (de) Zusammensetzungen und methoden zur wundbehandlung
ATE120203T1 (de) Methoden und zusammensetzungen für heilung von knochen.
AT338429B (de) Zur verankerung von implantaten und gelenkendoprothesen im knochen dienende mischung
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
ATA162587A (de) Verfahren zur herstellung von neuen benzolderivaten sowie von diese derivate enthaltenden pharmazeutischen zusammensetzungen und verfahren zur verringerung von entzündung bei tieren
NL7601628A (nl) Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese.
ATE228171T1 (de) Mikrobielle herstellung von vitamin b12 sowie herstellung und verwendung von zusammensetzungen die vitamin b12 in hohen konzentrationen enthalten
DE3690341D2 (en) Bone cement
EP0097057A3 (en) Method of producing human epidermal growth factor and pharmaceutical composition containing it
IT8821634A0 (it) Composizioni farmaceutiche che favoriscono la cicatrizzazione di ferite e procedimento per prepararle
IT1249004B (it) Metodo e composizione per la stimolazione della crescita di vegetali
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
HUT47591A (en) Process for production of nucleozides with healing effect and medical compositions containing them
CA846878A (en) Method of preparing surgical prosthetic implants for the repair and replacement of vascular organs and tissues in human bodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition